ICICI Securities Ltd | Retail Equity Research Aurobindo Pharma has acquired the Generis group in Portugal (subject to the fulfilment of certain anti-trust approvals), through its step down subsidiary Agile Pharma (Netherlands) for a consideration of ~135 million (~| 985 crore). The consideration is proposed to be financed via European debt. Generis' CY16 revenues were 64.8 million and EBITDA was 12.7 million. In CY17, the management expects revenues to increase to ~73 million and EBITDA to ~16 million mainly from new launches and...